While we have demonstrated that EDC1 is cytotoxic to thyroid cancer cells in subnanomolar concentrations, another limitation is the lack of data on EDC1′s toxicity in vivo since many cardiac glycosides failed clinical trials due to side effects as mentioned earlier. This evidence concerns the gene AMBP and thyroid cancer.